Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bee venom + honey is a combination of two natural bee-derived substances used in traditional and alternative medicine, particularly within the practice of apitherapy. Bee venom contains bioactive peptides such as melittin, apamin, and adolapin, which have demonstrated anti-inflammatory, pain-relieving, antioxidant, antibacterial, antiviral, and anticancer properties. Honey is well known for its antimicrobial activity and wound-healing effects. The combination is sometimes used topically or in other formulations to leverage both the anti-inflammatory effects of bee venom and the healing properties of honey. While each component has been studied individually for various indications—including arthritis symptom relief (bee venom) and wound care (honey)—the specific combination is primarily found in complementary medicine rather than mainstream pharmaceutical use. Mechanistically, bee venom acts by modulating inflammatory pathways (e.g., suppressing TNF-α and IL-1β), stimulating immune responses, providing local analgesia via peptide action on nerve cells, while honey provides a moist environment conducive to tissue repair with additional antimicrobial protection[1][2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bee venom + honey.